Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

259 Views

Poster Session: Antimicrobial Novel Agents

1707 - In vitro Activities of Ceftazidime-Avibactam and Comparator Agents against Enterobacterales and Pseudomonas aeruginosa Collected < 48 Hours and ≥48 Hours Post-Admission from Hospitalized Adult Patients, ATLAS Global Surveillance Program 2017-2020

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

MW

Mark Wise, PhD

Scientist
IHMA
Schaumburg, Illinois, United States

Co-Author(s)

GS

Gregory Stone, PhD

Director of Microbiology
Pfizer, Inc.
Groton, Connecticut, United States
DS

Daniel F. Sahm, PhD

VP Global Microbiology Services & Chief Scientific Officer
IHMA
Schaumburg, Illinois, United States